Could a common asthma drug help preemies breathe easier?

NCT ID NCT07101640

First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 21 times

Summary

This study looks at whether montelukast, a drug used for asthma, is safe and how it works in very premature babies at high risk for bronchopulmonary dysplasia (BPD), a serious lung condition. About 28 critically ill infants born before 28 weeks and weighing under 1000 grams will receive the drug. Researchers aim to find the best dose to help protect their lungs.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Arkansas Children's Hospital

    RECRUITING

    Little Rock, Arkansas, 72202, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • East Carolina University

    RECRUITING

    Greenville, North Carolina, 27858, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Medical Center of Southern Nevada

    RECRUITING

    Las Vegas, Nevada, 89102, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of North Carolina (UNC)

    RECRUITING

    Chapel Hill, North Carolina, 27599, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.